Overview

A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Evaluate 18F-AV-45 positron emission tomography (PET) imaging for distinguishing healthy control subjects, from subjects with Alzheimer's disease (AD) or Mild cognitive impairment (MCI).
Phase:
Phase 2
Details
Lead Sponsor:
Avid Radiopharmaceuticals